1. Home
  2. BGNE vs CF Comparison

BGNE vs CF Comparison

Compare BGNE & CF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BGNE
  • CF
  • Stock Information
  • Founded
  • BGNE 2010
  • CF 1946
  • Country
  • BGNE Cayman Islands
  • CF United States
  • Employees
  • BGNE N/A
  • CF N/A
  • Industry
  • BGNE Biotechnology: Pharmaceutical Preparations
  • CF Agricultural Chemicals
  • Sector
  • BGNE Health Care
  • CF Industrials
  • Exchange
  • BGNE Nasdaq
  • CF Nasdaq
  • Market Cap
  • BGNE 19.2B
  • CF 15.8B
  • IPO Year
  • BGNE 2016
  • CF 2005
  • Fundamental
  • Price
  • BGNE $175.87
  • CF $84.42
  • Analyst Decision
  • BGNE Buy
  • CF Hold
  • Analyst Count
  • BGNE 8
  • CF 13
  • Target Price
  • BGNE $253.69
  • CF $89.67
  • AVG Volume (30 Days)
  • BGNE 476.1K
  • CF 1.6M
  • Earning Date
  • BGNE 11-12-2024
  • CF 02-12-2025
  • Dividend Yield
  • BGNE N/A
  • CF 2.37%
  • EPS Growth
  • BGNE N/A
  • CF N/A
  • EPS
  • BGNE N/A
  • CF 6.29
  • Revenue
  • BGNE $3,351,304,621.00
  • CF $5,983,000,000.00
  • Revenue This Year
  • BGNE $969.39
  • CF N/A
  • Revenue Next Year
  • BGNE $24.79
  • CF $1.41
  • P/E Ratio
  • BGNE N/A
  • CF $13.42
  • Revenue Growth
  • BGNE 50.22
  • CF N/A
  • 52 Week Low
  • BGNE $126.97
  • CF $69.13
  • 52 Week High
  • BGNE $248.16
  • CF $94.46
  • Technical
  • Relative Strength Index (RSI)
  • BGNE 34.52
  • CF 39.16
  • Support Level
  • BGNE $174.50
  • CF $87.40
  • Resistance Level
  • BGNE $180.00
  • CF $90.99
  • Average True Range (ATR)
  • BGNE 6.73
  • CF 2.04
  • MACD
  • BGNE -2.17
  • CF -0.70
  • Stochastic Oscillator
  • BGNE 3.24
  • CF 0.50

About BGNE BeiGene Ltd.

Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeiGene is a commercial-stage biotechnology company with global sales. It focuses on oncology therapeutics and differentiates itself from other companies with a contract research organization-free, or CRO-free strategy. BeiGene runs global clinical trials with its own team. As of 2023, its core drug is Brukinsa, a small molecule drug for various blood cancers that makes up more than 50% of BeiGene's revenue.

About CF CF Industries Holdings Inc.

CF Industries is a leading producer and distributor of nitrogen, which is primarily used in fertilizers. The company operates nitrogen manufacturing plants primarily in North America. CF also produces nitrogen in the United Kingdom and holds a joint venture interest in a nitrogen production facility in Trinidad and Tobago. CF makes nitrogen primarily using low-cost US natural gas as its feedstock, making CF one of the lowest-cost nitrogen producers globally. The company is also investing in carbon-free blue and green ammonia, which can be used an alternative fuel to hydrogen or as a means to transport hydrogen.

Share on Social Networks: